ROMEOVILLE, Ill., Aug. 9 /PRNewswire-FirstCall/ -- Nanophase Technologies (Nasdaq: NANX), a technology leader in nanomaterials and nanoengineered products, noted that Dr. Richard Brotzman, Nanophase's Vice President of R&D, has been invited to present at the Particles 2005 conference August 13-16 in San Francisco. Particles 2005 is an international conference examining the science, technology, and business aspects of particle surface modification in different application areas including: chemical and drug delivery, chemical and biochemical diagnostics, and nano encapsulation for stabilization, modification and controlled release. Dr. Brotzman will be discussing Nanophase's integrated platform of scaled nanotechnologies to enable commercial applications. He plans to cover the Company's patented, patent-pending and proprietary nanomaterial technologies in nanoparticle manufacturing, nanoparticle surface treatments, and nanoparticle dispersion in both aqueous and solvent formats. Nanophase believes that providing an optimal nanomaterial solution for an application increases the value of the Company's products and decreases the time-to-market for new product introductions. Nanophase also noted that it continues to obtain new customers and receive associated orders for its nanomaterial solutions, consistent with the Company's business development initiatives in several markets. The Company recently obtained an order for a filtration application and orders from two new customers for Nanophase's line of optics polishing dispersions. Nanophase Technologies Corporation (NANX), http://www.nanophase.com , is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company owns or licenses 22 United States and 50 foreign patents and patent applications. Information about Nanophase may be found in the Company's public filings or on its website. This press release contains words such as "expects", "shall", "will", "believes" and similar expressions that are intended to identify forward- looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company's current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company's results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risk and uncertainties include the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company's dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company's nanocrystalline materials; the Company's manufacturing capacity and product mix flexibility in light of customer demand; the Company's limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company's dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; and other risks described in the Company's registration statement on Form 10K filed March 15, 2005 and other filings with the Securities and Exchange Commission. In addition, the Company's forward- looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.
SOURCE Nanophase Technologies Corporation